Klotho Therapeutics

Klotho Therapeutics is a biotechnology company headquartered in San Diego, California, that focuses on developing modified Klotho proteins to address the challenges of aging and associated diseases. Founded in 2016, the company aims to slow the progression of conditions such as chronic kidney disease, Alzheimer’s, osteoporosis, cancer, hypertension, and diabetes. Klotho, a naturally occurring protein identified in 1997, has shown promise in delaying the onset of major age-related illnesses. Research indicates that animals lacking Klotho live shorter, less healthy lives, while those with increased levels exhibit significant longevity benefits. Klotho Therapeutics is particularly focused on kidney failure, a critical health issue affecting millions in the U.S., and seeks to create effective therapies to improve patient outcomes. The firm has also filed patents for its modified Klotho proteins, highlighting their potential to redefine the approach to aging and related diseases.